The board meeting for C4 Therapeutics Inc is scheduled for today, for the purpose of C4 Therapeutics Inc First Quarter Earnings Results for 2026See details
C4 Therapeutics Inc has a share price target of US$ 12, revenue growth forecast of -39.9%, and profit growth estimate of -30.5% for FY26, based on top 8 analyst calls.